Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J J Prendergast

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Archives of Ophthalmology (Chicago, Ill. : 1929)|October 29, 2010
Congenital cataract and other anomalies following rubella in mother during pregnancy; a California surveyJ J PRENDERGAST
Diabetes Care|January 1, 1996
Severe autonomic neuropathy treated with subcutaneous insulin infusionJ J Prendergast, W Aubry
Henry Ford Hospital Medical Journal|January 1, 1970
Post-therapeutic thyroid reserve. Thyroid reserve in euthyroid patients after ablative therapy for diffuse toxic goiterJ J Prendergast, J M Miller
Diabetes Care|August 1, 1995
Over-delivery of insulin by insulin pumpsJ J Prendergast, C Dorsey, V Elsea
Diabetes Care|November 1, 1993
Exercise and hypoglycemiaJ J Prendergast, S Madan, L A Gavin
Oral Surgery, Oral Medicine, and Oral Pathology|June 1, 1971
The relationship between oral symptoms, insulin release, and glucose intoleranceH A Brody, J J Prendergast, S Silverman
JAMA|September 4, 1972
Synthetic salmon calcitonin. Treatment of Paget's disease and osteogenesis imperfectaE B Goldfield, B M Braiker, J J Prendergast, et al.
Diabetes Care|September 1, 1995
Effect of chronic intermittent intravenous insulin therapy on antihypertensive medication requirements in IDDM subjects with hypertension and nephropathyT T Aoki, E O Grecu, J J Prendergast, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|July 15, 2004
Effect of implanted insulin pumps on fluorescein transcapillary escape time in type 1 diabetes mellitusC E Ahlfors, P A Alley, J J Prendergast, et al.
Diabetes Care|January 1, 1995
Promotion and acceleration of diabetic ulcer healing by arginine-glycine-aspartic acid (RGD) peptide matrix. RGD Study GroupD L Steed, J J Ricotta, J J Prendergast, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Archives of Ophthalmology (Chicago, Ill. : 1929)|October 29, 2010
Congenital cataract and other anomalies following rubella in mother during pregnancy; a California surveyJ J PRENDERGAST
Diabetes Care|January 1, 1996
Severe autonomic neuropathy treated with subcutaneous insulin infusionJ J Prendergast, W Aubry
Henry Ford Hospital Medical Journal|January 1, 1970
Post-therapeutic thyroid reserve. Thyroid reserve in euthyroid patients after ablative therapy for diffuse toxic goiterJ J Prendergast, J M Miller
Diabetes Care|August 1, 1995
Over-delivery of insulin by insulin pumpsJ J Prendergast, C Dorsey, V Elsea
Diabetes Care|November 1, 1993
Exercise and hypoglycemiaJ J Prendergast, S Madan, L A Gavin
Oral Surgery, Oral Medicine, and Oral Pathology|June 1, 1971
The relationship between oral symptoms, insulin release, and glucose intoleranceH A Brody, J J Prendergast, S Silverman
JAMA|September 4, 1972
Synthetic salmon calcitonin. Treatment of Paget's disease and osteogenesis imperfectaE B Goldfield, B M Braiker, J J Prendergast, et al.
Diabetes Care|September 1, 1995
Effect of chronic intermittent intravenous insulin therapy on antihypertensive medication requirements in IDDM subjects with hypertension and nephropathyT T Aoki, E O Grecu, J J Prendergast, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|July 15, 2004
Effect of implanted insulin pumps on fluorescein transcapillary escape time in type 1 diabetes mellitusC E Ahlfors, P A Alley, J J Prendergast, et al.
Diabetes Care|January 1, 1995
Promotion and acceleration of diabetic ulcer healing by arginine-glycine-aspartic acid (RGD) peptide matrix. RGD Study GroupD L Steed, J J Ricotta, J J Prendergast, et al.
Pageof 2